SCHEMBL207987

SCHEMBL207987

Clc1ccc2cc[c]nc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.47
DYRK1A Q13627 2/20 0.38
F7 P08709 1/20 0.38
F3 P13726 1/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
PIK3CG P48736 1/20 0.37
CYP2A6 P11509 1/20 0.37
CMA1 P23946 1/20 0.36
AHR P35869 1/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208188 0.83 F7 (0.38) NR4A2DYRK1AF7F3HTR3E
SCHEMBL2718077 0.77 MAPK13 (0.34) DYRK1AMAPTPOLBPDGFRBPDGFRA
SCHEMBL411739 0.75 CYP1A2 (0.57) CYP2A6MAPTCYP1A2KDM4EALDH1A1
SCHEMBL209493 0.75 KDM4E (0.38) CYP2A6AHRMAPTLMNACYP1A2
SCHEMBL208857 0.75 BACE1 (0.48) DYRK1ACYP2A6AHRMAPTCYP1A2
SCHEMBL3384257 0.75 ALDH1A1 (0.47) MAPTLMNACYP1A2ALOX15PDGFRB
SCHEMBL406456 0.71 BACE1 (0.43) DYRK1AF7F3MAPTLMNA
SCHEMBL3384607 0.71 ALDH1A1 (0.47) CYP2A6MAPTLMNACYP1A2THRB
SCHEMBL5749720 0.71 KDM4E (0.37) CYP2A6KDM4EALDH1A1
SCHEMBL16289184 0.71 ALDH1A1 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116178297-B Drimane type sesquiterpene heterocyclic compound and preparation method and application thereof 贵州大学 2024-05-17 CN claimed
CN-116178297-A Drimane type sesquiterpene heterocyclic compound and preparation method and application thereof 贵州大学 2023-05-30 CN claimed
EP-2389066-B1 CYCLOPENTADIONE DERIVED HERBICIDES SYNGENTA LTD (GB) 2017-07-05 EP claimed
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP claimed
US-8895474-B2 Herbicidally active cyclopentanediones and derivatives thereof, and their use in controlling weeds SYNGENTA LIMITED (GB) 2014-11-25 US claimed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US claimed
US-8785475-B2 Lipoic acid derivatives CORNERSTONE PHARMACEUTICALS, INC. (US) 2014-07-22 US claimed
US-20100292266-A1 Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase JANSSEN PHARMACEUTICA NV (BE) 2010-11-18 US claimed
EP-2023728-A2 OXAZOLYL PIPERIDINE MODULATORS OF FATTY ACID AMIDE HYDROLASE Janssen Pharmaceutica, N.V. (BE) 2009-02-18 EP claimed
US-7309718-B2 Dibenzocycloheptene compound UBE INDUSTRIES, LTD. (JP) 2007-12-18 US claimed
EP-0737186-A1 PROCESS FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS MERCK & CO. INC. (US) 1996-10-16 EP claimed
WO-1996005206-A1 NOVEL PROCESS FOR THE PREPARATION OF DIISOPINOCAMPHEYLCHLOROBORANE MERCK & CO., INC. (US) 1996-02-22 WO claimed
WO-1995018107-A1 PROCESS FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS MERCK & CO., INC. (US) 1995-07-06 WO claimed
US-5399703-A Antiallergens NIPPON SHINYAKU COMPANY, LIMITED (JP) 1995-03-21 US claimed
EP-0536310-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1993-04-14 EP claimed
EP-0536310-A4 CHEMICAL COMPOUNDS. SMITHKLINE BEECHAM CORP (US) 1993-02-05 EP claimed
EP-0523046-A1 2-ANILINO PHENYLACETIC ACID DERIVATIVES AS INHIBITORS OF PLA 2? AND LIPOXYGENASE AMERICAN HOME PRODUCTS CORPORATION (US) 1993-01-20 EP claimed
WO-1992000279-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1992-01-09 WO claimed
WO-1991006539-A1 2-ANILINO PHENYLACETIC ACID DERIVATIVES AS INHIBITORS OF PLA2 AND LIPOXYGENASE AMERICAN HOME PRODUCTS CORPORATION (US) 1991-05-16 WO claimed
US-4996214-A Respiratory systyem disorders SMITHKLINE BEECHAM CORPORATION (US) 1991-02-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292266-A1 Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase FAAH, FAAH2, APEH NR4A2 949/4885DYRK1A 4745/4885F7 3195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.